Patheon has launched cell based assay services to support biopharmaceutical product development. The new services will strengthen Patheon’s existing analytical capability in biopharmaceutical analysis, according to a company statement. Cell based assays are a key technology used in determining the biological potency of biopharmaceuticals required for product licensing procedures. Biological potency analytics and the required supporting capabilities for tissue culture, such as assessment...